Bruce M. Ewenstein

8.9k citations

149 papers · 6.9k indexed · h-index 49

Impact in

Hematology top 0.1%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Hemostasis and retained surgical items
- Blood groups and transfusion
Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

Hematology 110
- Hemophilia Treatment and Research 81
- Platelet Disorders and Treatments 50
- Blood Coagulation and Thrombosis Mechanisms 34
- Chronic Myeloid Leukemia Treatments 17
- Hemostasis and retained surgical items 10
Genetics 37
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 23

Co-authors: Gerald Spotts Victor S. Blanchette Hiroshi Uehara W. Keith Hoots S.G. Nathenson Cindy Leissinger P Schroth Kathelijn Fischer
Journals: Blood (37 papers)Haemophilia (30 papers)Journal of Thrombosis and Haemostasis (7 papers)Thrombosis and Haemostasis (7 papers)Transfusion (3 papers)
Partner nations: United States United Kingdom Austria

In The Last Decade

Bruce M. Ewenstein

145 papers receiving 6.5k citations

Peers

Countries citing papers authored by Bruce M. Ewenstein

Since Specialization

Citations

This map shows the geographic impact of Bruce M. Ewenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce M. Ewenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce M. Ewenstein more than expected).

Fields of papers citing papers by Bruce M. Ewenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce M. Ewenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce M. Ewenstein. The network helps show where Bruce M. Ewenstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruce M. Ewenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce M. Ewenstein Line = papers co-authored together Bruce M. Ewenstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sex-specific NLRP3 activation in neutrophils promotes neutrophil recruitment and NETosis in the murine model of diffuse alveolar hemorrhage Frontiers in Immunology ·Pierre‐André Jarrot, Niki Pantazi, William Chan, Katherine Tomaszewski Arnold, Dorothy M. Conroy, Pierre Cunin, Camila M. Silva, Stéphane Robert, Peter A. Nigrović, Bruce M. Ewenstein, Denisa D. Wagner	2024	4
2	Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trial Journal of Thrombosis and Haemostasis ·Tina Manon‐Jensen, Srilatha Tangada, Cecilie L. Bager, Pratima Chowdary, Robert Klamroth, Annette von Drygalski, Jerzy Windyga, Miguel A. Escobar, Peder Frederiksen, Werner Engl, Bruce M. Ewenstein, M.A. Karsdal	2023	4
3	Psychometric evaluation of a patient-reported outcomes instrument for congenital thrombotic thrombocytopenic purpura Journal of Patient-Reported Outcomes ·Abiola Oladapo, Silvia Magri, Gabriela Cordero-Schmidt, Pellicanò Domenica Savia, Janek Stoeck, Lovepreet Singh Brar, Judah Indra Gunawan, Marie Scully, Bruce M. Ewenstein	2023	2
4	BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression Blood ·Barbara A. Konkle, Christopher Walsh, Miguel A. Escobar, Neil C. Josephson, Guy Young, Annette von Drygalski, Scott McPhee, R. Jude Samulski, Ivan Bilić, Maurus de la Rosa, Birgit M. Reipert, Hanspeter Rottensteiner, Friedrich Scheiflinger, John Chapin, Bruce M. Ewenstein, Paul E. Monahan	2020	138
5	Co-Prevalence of Pre-Existing Immunity to Different Serotypes of Adeno-Associated Virus (AAV) in Adults with Hemophilia Blood ·Melody Bunting, J.-L. Besse, Ying Tang, Bagirath Gangadharan, Maurus de la Rosa, Bruce M. Ewenstein	2019	10
6	Use of Bypassing Agents and Risk of Thromboembolic Events in Patients with Haemophilia and Inhibitors Thrombosis and Haemostasis ·Katsiaryna Bykov, Rhonda L. Bohn, Bruce M. Ewenstein, John D. Seeger, Jerry Avorn, Brian T. Bateman	2017	6
7	Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease Blood ·Joan Cox Gill, Giancarlo Castaman, Jerzy Windyga, Peter A. Kouides, Margaret V. Ragni, Frank W.G. Leebeek, Gökalp Nuri Selçuk, Jinzhu Lv, Sandor Fritsch, Borislava G. Pavlova, 潘顺顺, Bruce M. Ewenstein	2015	104
8	Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A Haemophilia ·Rebecca Kruse‐Jarres, Jean St‐Louis, A. Greist, Amy Shapiro, Hedy Smith, Pratima Chowdary, Gerald E Voecks, Edward D. Gomperts, C. Bourgeois, Min Mo, Agnieszka Romanowicz, 刘昭纯, Bruce M. Ewenstein	2015	128
9	Advancing personalized care in hemophilia A: ten years’ experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method Biologics ·Erik Berntorp, Gerald Spotts, Lisa Patrone, Bruce M. Ewenstein	2014	22
10	Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial Blood ·Pier Mannuccio Mannucci, Christine L. Kempton, Carolyn M. Millar, Edward H. Romond, Amy D. Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, T. T. Yee, Robert Klamroth, Wing-Yen Wong, Jinzhu Lv, Werner Engl, Peter L. Turecek, Jupiter Subur, Bruce M. Ewenstein	2013	87
11	The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study Haemophilia ·Robert Klamroth, H. Pöllmann, Cédric Hermans, A. Faradji, Aaron Yarlas, J. Epstein, Bruce M. Ewenstein	2011	51
12	Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring Journal of Thrombosis and Haemostasis ·Sven Björkman, Victor S. Blanchette, Kathelijn Fischer, M. Oh, Gerald Spotts, P Schroth, S. Fritsch, Lisa Patrone, Bruce M. Ewenstein, Peter W. Collins	2010	99
13	Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A Journal of Thrombosis and Haemostasis ·P. Collins, Victor S. Blanchette, Kathelijn Fischer, Masumeh Samari-Khalaj, M. Oh, S. Fritsch, P Schroth, Gerald Spotts, Jan Astermark, Bruce M. Ewenstein	2008	262
14	Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method1Proceedings of a special symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12–18, 2003, Birmingham, UK Seminars in Hematology* ·Bruce M. Ewenstein, Peter W. Collins, Michael D. Tarantino, Claude Négrier, Victor S. Blanchette, Merris D. Obie, Derek Baker, Gerald Spotts, Martha G. Sensel, Nichakan Inthitanon	2004	13
15	Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate‐P^®): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy Haemophilia ·Joan Cox Gill, Bruce M. Ewenstein, Arthur R. Thompson, Guenther Mueller‐Velten, Bruce A. Schwartz, (unknown)	2003	55
16	Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B Transfusion ·Bruce M. Ewenstein, J. Heinrich Joist, Amy D. Shapiro, Thomas Hofstra, Cindy Leissinger, Stephanie Seremetis, Martin I. Broder, Guenther Mueller‐Velten, Bruce A. Schwartz, (unknown)	2002	85
17	Factor IX Inhibitors and Anaphylaxis in Hemophilia B The American journal of pediatric hematology/oncology ·Indira Warrier, Bruce M. Ewenstein, Marion A. Koerper, Amy D. Shapiro, Nigel S. Key, Donna DiMichele, Robert Miller, John Pasi, Georges E. Rivard, Steve S. Sommer, Jacob Katz, Frauke Bergmann, Rolf Ljung, Pia Petrini, Jeanne M. Lusher	1997	128
18	Hepatitis A among persons with hemophilia who received clotting factor concentrate - United States, September-December 1995 (Reprinted from MMWR, vol 45, pg 29-32, 1996) JAMA ·C.L. Stern, 寛塚越, 金昌, R.A. Pushkareva, Bruce M. Ewenstein, Alfred DeMaria, M. Manco‐Johnson, Bernardo Ueno	1996	10
19	Regulated Secretion in Vascular Endothelium Advances in experimental medicine and biology ·Bruce M. Ewenstein, Brian C. Jacobson, D. Sedley	1991	6
20	Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation Journal of Cellular Physiology ·Douglas V. Faller, Stella Kourembanas, David Ginsberg, Robert L. Hannan, Tucker Collins, Bruce M. Ewenstein, Jordan S. Pober, Ramana Tantravahi	1988	29

About Bruce M. Ewenstein

Bruce M. Ewenstein is a scholar working on Hematology, Genetics, Internal Medicine, Immunology and Immunology and Allergy, having authored 149 papers that have together received 6.9k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (81 papers), Platelet Disorders and Treatments (50 papers), Blood Coagulation and Thrombosis Mechanisms (34 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (23 papers), Chronic Myeloid Leukemia Treatments (17 papers), Complement system in diseases (11 papers), Hemostasis and retained surgical items (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (9 papers). The work is most often cited by research in Hematology (4.7k citations), Genetics (1.5k citations), Internal Medicine (320 citations), Immunology (889 citations) and Immunology and Allergy (188 citations). Bruce M. Ewenstein has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Gerald Spotts, Victor S. Blanchette, Hiroshi Uehara, W. Keith Hoots, S.G. Nathenson, Cindy Leissinger, P Schroth, Kathelijn Fischer, J S Pober and Peter W. Collins. Their work appears in journals such as Blood, Haemophilia, Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact